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8 with DAPI (1μg/mL) for 10 min. The morphologic changes of apoptosischaracteristic nuclei were examined by confocal microscopy (Olympus, Tokyo, Japan).
Cell cycle analysis
For detecting DC120-induced apoptosis, cells were cultured in six-well plate and exposed to DC120. The cells were harvested and fixed with 70% ethanol and incubated overnight at -4°C. Then the cells were washed and resuspended in 1 mL of staining solution (50 μ g/mL PI, 50 μ g/mL RNase) for 15 min. The PI fluorescence associated with DNA was measured by flow cytometer (Beckman Coulter). The percentages of nuclei in sub-G1 phase of the cell cycle were calculated by MultiCycle software.
Western blot analysis
The cells were harvested and lysed in Equal amounts of protein (20μg-40μg) were separated electrophoretically on 8% -15% SDS-polyacrylamide gels and transferred onto PVDF membranes (Millipore), and analyzed as previously described (Deng et al., 2009 ).
Plasmids and transfection
For inhibition of AKT activity, the hairpin RNA (shRNA) sequences against AKT1 (5'-GCTACTTCCTCCTCAAGAATG -3' (Irie et al., 2005) for intense immunofluorescence (Deng et al., 2009; Zhang et al., 2008) .
In Vivo Antitumor Activity
BALB/c nude mice were obtained from Hunan Slac Jingda Laboratory Animal
Co. Ltd and were 4 to 6 weeks old. All manipulations were performed under sterile conditions. The procedures involving mice and their care were in accordance with the National Institues of Health Guide for the care and use of Laboratory Animals with the UKCCCR (UKCCCR, 1998). Tumor xenografts were established by 2×10 6 CNE2 cells injected s.c. into nude mice. Mice were randomly divided into 3 groups and each group contained 6 mice. Treatments were initiated on day 7 after inoculation, by which time the tumor volume had reached ~50mm
TUNEL staining assay
In Situ Cell Death Detection Kit (Roche, Switzerland) was used to evaluate DC120-induced apoptosis in vivo. Frozen tumor sections were incubated in blocking solution for 10 min and permeabilisation solution for 2 min on ice. Then 50μl TUNEL reaction mixture was added on samples for 60 min at 37°C in a humidified atmosphere in the dark. After counter-staining with DAPI (1μg/ml), frozen sections were observed using confocal microscopy (Olympus). TUNEL-positive nuclei were stained green, and all other nuclei were stained blue ( Markaryan et al., 2008) .
Statistic Analysis
The student's t test was used to evaluate the statistical significance of the result at the 95% Confidence Level, and a P value less than 0.05 was considered to indicate statistical significance.
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Results

DC120 inhibited AKT kinase activity in vitro
We used biochemistry method (Z'-LYTE™ Kinase Assay Kits-Ser/Thr 6 Peptide)
to evaluate the effect of these 2-(methylaminopyrimidinyl) thiazole-5-carboxamide compouds on the AKT kinase activity in cell-free system. In this experiment, Z-LYTE™ Ser/Thr 6 Peptide was used as a substrate; Thus, the changes of Z-LYTE™ Ser/Thr 6 Peptide phosphorylation can directly reflect the AKT kinase activity. As expected, we screened out several compounds including compoud DC120. The results showed DC120 could concentration-dependently suppress phosphorylation of Z-LYTE™ Ser/Thr 6 Peptide and the value of EC50 was about 153 nM, while EC50 value for Staurosporine (positive control) was about 122nM (Figure 1 ). We also used HTScan® Akt1 Kinase Assay Kit to confirm the AKT inhibitory effect of DC120.
The results showed that DC120 could concentration-dependently suppress phosphorylation of eNOS (Ser1177) (Supplementary Table 1 ). To further test whether DC120 has off-target effects, we also employed KINOMEscan's in vitro competition binding assay to evaluate DC120 against a panel of distinct human protein kinases.
The results showed that DC120 selectively inhibited AKT but not JNK, ERK, P38, EGFR, CDK2, etc. At the concentration of 100 nM DC120, the percentage of AKT kinase binding to the immobilized ligand was only 15% (Supplementary Table 2 ).
Taken together, all these data indicated that DC120 could inhibit AKT kinase activity in vitro obviously.
DC120 suppressed proliferation and induced apoptosis in cancer cells
This article has not been copyedited and formatted. The final version may differ from this version. Figure 1) . In this study, we focused on the effect of DC120 on CNE2 and MDA-MB-453 cell lines which showed more aberrantly activated AKT signaling pathway in cells observed in our previous work.
As shown in Figure Figure 3D ). These data indicated that DC120 indeed induced apoptosis in cancer cells, which was consistent with the results of the MTT growth-inhibition assay.
The growth inhibition of DC120 on cancer cells depending on AKT activity
To further confirm DC120 targeting AKT kinase, retroviral vectors encoding short hairpin RNA (shRNA) sequences against AKT1 were stably transfected to CNE2 cells.
The downregulation of phospho-AKT and AKT1 was at least 75% ( Figure To directly examine of the cell killing, the sub-G1 fraction was tested using flow cytometric analysis. The results showed that DC120 decreased cell viability mainly due to the induction of apoptosis, as shown by the increase of sub-G1 cells. Also we This article has not been copyedited and formatted. The final version may differ from this version. was consistent with the MTT assay. Thus, the data further confirmed that AKT kinase was indeed the target of DC120 treatment in cancer cells.
Effect of DC120 on phosphorylation of AKT and its downstream targets in cancer cells
As the AKT kinase activity is regulated by phosphorylation on two sites, threonine 
Antitumor Activity of DC120 in Vivo
Because of the potent growth inhibition of DC120 in vitro, its antitumor properties were further examined in vivo. CNE2 xenografts were established and given i.p. 
U0126 enhanced the DC120-induced apoptosis
In this study, we tested the effect of DC120 on the phosphorylation of MAPKs signaling pathway. The results revealed that phospho-JNK, phospho-P38, and phospho-ERK all increased obviously after DC120-treatment for 24hr in CNE2 and MDA-MB-453 cells, without affecting the total amount of JNK, P38, and ERK ( Figure 7A ). This might be DC120 induces a feedback loop to activate MAPKs pathway. The activation of feedback loops such as MAPKs pathway by DC120 prompted us to detect the apoptotic effect of the combination of MEK inhibitor U0126
and DC120 on cancer cells. We noticed that treatment with U0126 and DC120
This article has not been copyedited and formatted. The final version may differ from this version. inhibited phospho-ERK expression drastically ( Figure 7B ). We also found that the two-drug combination resulted in more apoptotic cells than either single-drug treatment alone. Once combined with U0126, DC120-induced apoptosis increased from 13.9% to 27.5% in the CNE2 cells and from 22.1% to 64.1% in the MDA-MB-453 cells (p<0.01, Figure 7C ). These results indicated that U0126
effectively enhanced DC120-induced apoptosis in vitro.
This article has not been copyedited and formatted. The final version may differ from this version. Figure 5A , 5B, Figure 6C ). We further observed that FKHR translocated into the nucleus upon the reversal of its phosphorylation induced by DC120 in cancer cells ( Figure 5C ). Because reduction in phosphorylation of these downstream effectors occurred early, these effects could not , 2010) . In the present study, we noticed that DC120 induced a feedback loop to activate MAPKs pathway and U0126
effectively enhanced DC120-induced apoptosis in vitro, which indicated that the combination of these two agents has a significant synergistic effect (Figure 7 ).
Additionally, DC120 combination with other anticancer agents, such as with RAD001
(a mTOR inhibitor) or radiotherapy is already being conducted in our laboratory, and some exciting data has been achieved (data not shown). To explore the combination efficacy of DC120 with other anticancer agents in the further study, it will be useful for DC120 as a leading compound targeting AKT signal pathway or for further development.
In summary, our data provide evidence of a sustained antitumor effect and a promising development of DC120. DC120 is a potent inhibitor of AKT kinase in This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
